| Alprazolam Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Alprazolam 0.5 mg | tablet | oral | 1.0 each | OTC |
| Alprazolam 1 mg | tablet | oral | 1.0 each | OTC |
| Alprazolam 0.25 mg | tablet | oral | 1.0 each | OTC |
| Alprazolam 2 mg | tablet | oral | 1.0 each | OTC |
| Alprazolam 0.5 mg/5 mL | solution | oral | 5.0 milliliter(s) | OTC |
| Alprazolam - | powder | compounding | 100.0 gram(s) | OTC |
| Alprazolam 1 mg/mL | concentrate | oral | 1.0 milliliter(s) | OTC |
Posted by clee 5 months ago
I have taken this med for 2 years now and have found that it makes me very forgetful. My memory is totally shot. I am weani...
Posted by thelillygal about 1 year ago
I have been taking this for about 5 months. So far, I don't think have any side effects. ( I don't get sleepy or anything) ...
Posted by lilacpatty over 4 years ago
i have been taking alprazolam for many yrs for anxiety, i have gone on several anti depressants zoloft, paxil and celxa. they...
Ledger overdose: Hunt for drug supplier - Telegraph.co.uk
"Mr Heath Ledger died as the result of acute intoxication by the combined effects of oxycodone, hydrocodone, diazepam, temazepam, alprazolam and doxylamine. ...
Thu Feb 07 06:50:05 -0500 2008
Heath Ledger leaves everything he owned to his parents and three ... - Showbiz Spy
all 9 news articles
Sat Mar 08 11:24:17 -0500 2008
Dayton nurse put into ARD program - Leader Times
Drum told police she asked Miller to purchase a bottle of Alprazolam for her personal use in February 2007 when they both worked in Mercurio's office, ...
Fri Mar 07 08:27:10 -0500 2008
alprazolam - A triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities. Alprazolam binds to a specific site distinct from the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) binding site on the benzodiazepine-GABA-A-chloride ionophore receptor complex located in the limbic, thalamic and hypothalamic regions of the central nervous system (CNS). This binding causes an allosteric modification of the receptor and enhances the affinity of GABA to the receptor leading to an increase in the frequency of chloride-channel opening events. This leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential and leads to a decrease in neuronal excitability.